Source: ERJ Open Res, 6 (1) 00030-2019; 10.1183/23120541.00030-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Dan Kibuule, Philomein Aiases, Nunurai Ruswa, Timothy William Rennie, Roger K. Verbeeck, Brian Godman, Mwangana Mubita. Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia. ERJ Open Res, 6 (1) 00030-2019; 10.1183/23120541.00030-2019

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of TB cases failing or defaulting the first TB treatment, in Romania Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Tuberculosis-related deaths before and after the implementation of DOTS control program Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007 Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Outcomes of DOTS and DOTS Plus regimens implementing among patients with pulmonary tuberculosis relapses Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002 A follow up Study of TB patients put on DOTS from South India Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Co-morbid conditions associated with tuberculosis (TB): Results from a 1-day, point-prevalence study in 204,912 physician diagnosed patients from 880 cities and towns in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008 Intrahospital mortality of tuberculosis – our experience of national tuberculosis program implementation Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006 A two-year post-treatment follow-up of multi-drug resistant tuberculosis cases who completed a programmatic MDR-TB management at the lung center of the Philippines – a preliminary report Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 DOTS program is associated with a reduction of multidrog resistant tuberculosis prevalence in new cases Source: Annual Congress 2003 - The various appearance of resistance Year: 2003 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Experience of managing TB/HIV infection in a regional UK center over a 5 year period Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015